Spironolactone for PCOS: What It Treats, the Timeline, and the Potassium Rule

What spironolactone actually treats

Spironolactone is an anti-androgen, prescribed off-label in PCOS for hirsutism and hormonal acne — not for irregular cycles, insulin resistance, or fertility. It works by blocking androgens at the receptor, which is a different mechanism entirely from metformin’s effect on insulin, and the two are sometimes prescribed together for different reasons rather than as alternatives to each other. Metformin for PCOS covers that separate drug and what it targets if insulin resistance, not androgen symptoms, is what you are trying to treat.

A 2023 meta-analysis that informed the current international guideline found anti-androgens, spironolactone included, improved hirsutism more than metformin (WMD −1.59, 95% CI −3.06 to −0.12) but were not superior to placebo when metformin was not the comparator — a genuinely mixed result that depends heavily on what spironolactone is being measured against. The guideline’s own conclusion is that anti-androgens are reasonable where combined oral contraceptives are contraindicated, poorly tolerated, or have not worked after a minimum six-month trial — not a first-line choice ahead of them.

How long does spironolactone actually take to work?

Six months is the realistic minimum, and most of the evidence behind spironolactone’s use in hirsutism comes from trials that ran six to twelve months. A Cochrane review covering 157 hirsutism trials found treatment duration across the field was six to twelve months, and the same review found spironolactone 100 mg daily reduced Ferriman-Gallwey hirsutism scores more than placebo (MD −7.69, 95% CI −10.12 to −5.26) — low-quality evidence, but the best available.

A large, non-PCOS trial gives the clearest illustration of how slow this drug is. The SAFA trial randomised 410 women with acne to spironolactone or placebo, and found no significant difference in quality-of-life scores at week 12, but a clear difference by week 24 (82% reporting improvement on spironolactone versus 63% on placebo). If you judge spironolactone at six or eight weeks, the trial data says you are judging it too early — the honest answer is that three months in, you may see little; six months in is where the evidence actually looks.

That last row matters: a 2026 systematic review searching specifically for PCOS spironolactone trials found only five open-label RCTs met inclusion criteria, and current evidence does not show a significant difference from metformin. Spironolactone’s evidence base is stronger for hirsutism in general than for PCOS-diagnosed hirsutism specifically — a distinction worth knowing before treating it as a settled question.

The shedding phase people panic about, and what it actually is

A number of people starting anti-androgen treatment for hair thinning notice more hair coming out in the first weeks, not less, and understandably assume the drug is making things worse. This is usually a hair-cycle phenomenon rather than a spironolactone-specific effect: hair follicles cycle between growth and rest, and anything that shifts the balance of that cycle — including, more directly, minoxidil when the two are prescribed together, which is common — can produce a temporary increase in shedding before any visible improvement. Spironolactone’s own mechanism is slower and more hormonal than mechanical, so an early shed is more often coincidence, normal cycle variation, or a co-prescribed treatment than a sign spironolactone has failed. Given that real improvement takes months either way, a rough first few weeks is not, on its own, a reason to stop.

The potassium rule, and what the evidence actually says about the risk

Spironolactone is potassium-sparing, and hyperkalemia is the safety reason prescribers order follow-up bloodwork. The best data on how often it actually happens in a low-risk population comes from a retrospective study of 974 healthy young women taking spironolactone, which found a hyperkalemia rate of 0.72% across 1,802 potassium measurements — statistically indistinguishable from the 0.76% baseline rate in women not taking the drug. That study’s own conclusion was that routine potassium monitoring is unnecessary in healthy young women without kidney or cardiac disease — but “healthy, without those conditions” is doing real work in that sentence, and it is a determination your prescriber makes, not one to assume for yourself.

PCOS-specific data points the same direction with a caveat. A 2024 study followed 78 women with PCOS on spironolactone for a minimum of 12 months, with 327 total potassium measurements — 19 of 243 post-exposure readings were above the reference range, and every one was classified as mild (5.1–5.5 mEq/L). Fifteen of those women were also taking an ACE inhibitor or ARB alongside spironolactone, which is exactly the combination that raises hyperkalemia risk beyond the baseline figure above.

The interaction that turns monitoring into essential

Combine spironolactone with an ACE inhibitor, an ARB, an NSAID taken regularly, or a potassium supplement, and the calculus changes: all four reduce potassium excretion or increase potassium load through a different route, and stacked on spironolactone’s own potassium-sparing effect, the combination is the scenario the monitoring exists for. This is exactly the combination present in a subset of the PCOS cohort above, and it is why “I feel fine” is not a substitute for the bloodwork — hyperkalemia is frequently asymptomatic until it is not.

Why reliable contraception is not optional

Spironolactone is teratogenic. Its antiandrogenic mechanism — the same one that treats hirsutism — can feminize the genitals of a male fetus, which is why it is not recommended in pregnancy and why reliable contraception is required alongside it for anyone who could conceive. Human data on this risk is limited, and a 2024 case report illustrates both the concern and the uncertainty around it: a woman inadvertently exposed to spironolactone for a week at 16 weeks of pregnancy delivered a healthy male infant with normal genitalia — a reassuring single case, but the report’s own authors describe human evidence on this question as “scarce and largely inconclusive.” One normal outcome does not make the drug safe in pregnancy; it means the precaution exists because of a real, mechanistically clear risk that has not been, and should not be, tested in controlled human trials.

Because spironolactone is frequently prescribed alongside a combined oral contraceptive for exactly this reason — and because the pill has its own effects on hirsutism and acne worth understanding separately — birth control for PCOS covers what the contraceptive itself does and does not treat.

Who this will not help

Spironolactone will not regulate your cycles, will not improve ovulation, and will not help you conceive — it is not tested for, or recommended for, any fertility outcome, and reliable contraception is required precisely because pregnancy is the outcome it is meant to prevent while you take it. If irregular cycles or fertility are your primary concern, hirsutism is the indication spironolactone actually has evidence for, and a different conversation is needed for the reproductive side of PCOS.

It also will not outperform metformin for insulin resistance or metabolic markers — that was never its mechanism — and the 2026 systematic review above found no significant PCOS-specific advantage over metformin even for the androgen symptoms both are sometimes compared on. If your evidence priority is metabolic, the PCOS supplements guide ranks where non-prescription options and metformin actually stand.

You may see PCOS referred to as polyendocrine metabolic ovarian syndrome (PMOS) after a 2026 global consensus of more than 50 organisations renamed it. Spironolactone’s evidence, dosing, and precautions above are unchanged by the rename; this article uses PCOS because that is still what people search.

Common questions

Combining spironolactone with anything else on this site’s list of options? The supplements and medications section is the place to check what else you are taking against it before you start.